Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

抗原特異抑制細胞機能と自己免疫疾患

J How, V V Row, R Volpé

    Lancet (London, England)
    |August 25, 1984
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.

    Gynecologic oncology·2015
    Same author

    Measurement of the azimuthal anisotropy of neutral pions in Pb-Pb collisions at sqrt[s](NN)] = 2.76 TeV.

    Physical review letters·2014
    Same author

    Observation of the associated production of a single top quark and a W boson in pp collisions at sqrt[s] = 8 TeV.

    Physical review letters·2014
    Same author

    Measurement of inclusive W and Z boson production cross sections in pp collisions at sqrt[s] = 8 TeV.

    Physical review letters·2014
    Same author

    Measurements of tt spin correlations and top-quark polarization using dilepton final states in pp collisions at sqrt[s]=7  TeV.

    Physical review letters·2014
    Same author

    Search for top-quark partners with charge 5/3 in the same-sign dilepton final state.

    Physical review letters·2014
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る